BioWorld MedTech

Feb. 22, 2017

Trust still an issue for some minorities in clinical studies

Screening a risky, beneficial business

Medrobotics picks up $20M to develop a host of additional indications for its Flex Robotic System

Medrobotics Corp. has closed on a $20 million preferred stock financing. Proceeds will be used to fund the Raynham, Mass.-based company's expansion into new surgical applications for its Flex Robotic System. Read More

Roche, Dexcom roll out competing next-gen CGM glucose sensors

Today's news in brief

BioWorld

BioWorld briefs for March 19, 2026.

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

BioWorld MedTech

Feb. 22, 2017

Trust still an issue for some minorities in clinical studies

Screening a risky, beneficial business

Appointments and advancements

Daily M&A

Financings

Other news to note

Product briefs

MDD's Oncology Extra